[The expression and significance of nerve growth factor and its receptors in pancreatic ductal adenocarcinoma]. 2009

Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
Oncological Department, Rizhao People's Hospital, Rizhao Cancer Therapy Center, Rizhao 276826, China. menglx001623@163.com

OBJECTIVE To investigate nerve growth factor (beta-NGF) and its receptors expression in human pancreatic ductal adenocarcinoma. METHODS Expression and distribution of beta-NGF, tyrosine kinase A (TrKA) and P75(NGFR) were detected in operation tissue specimens of pancreatic ductal adenocarcinoma with immunohistochemistry and real-time PCR. Relations of beta-NGF and its receptors with clinical pathological characters, especially nerve invasion were analyzed. RESULTS beta-NGF and TrKA expression are higher in pancreatic adenocarcinoma than normal pancreas, and the differences are significant (P < 0.01). beta-NGF and TrKA expression are associated with the differentiation grades (DG), lymphatic node metastasis, nerve invasion and surgical pathological stages. Poorer of DG and later stages, more expression of beta-NGF and TrKA. beta-NGF and TrKA expression have positive correlations. beta-NGF, TrKA and P75(NGFR) mRNA expression have significantly increased 3.84, 4.23 and 2.41 times than normal tissues by real-time PCR, respectively. CONCLUSIONS beta-NGF and TrKA might play potential roles in carcinogenesis for pancreatic cancer, have affinity with clinicopathological characters of pancreatic cancer. beta-NGF and TrKA may have mutual effect in signal transduction leading to perineural invasion of pancreatic carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D020800 Receptor, Nerve Growth Factor A low affinity receptor that binds NERVE GROWTH FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; and neurotrophin 4. NGF Receptor,NGFR Protein,Nerve Growth Factor Receptor p75,Nerve Growth Factor Receptor, Low-Affinity,GP80-LNGFR,Neurotrophin Receptor p75,Neurotropin Receptor p75,gp75 NGFR,p75 Neurotrophin Receptor,GP80 LNGFR,NGFR, gp75,Nerve Growth Factor Receptor, Low Affinity,Neurotrophin Receptor, p75,Receptor p75, Neurotrophin,Receptor p75, Neurotropin,Receptor, NGF,Receptor, p75 Neurotrophin,p75, Neurotrophin Receptor,p75, Neurotropin Receptor
D020917 Receptor, trkA A protein-tyrosine kinase receptor that is specific for NERVE GROWTH FACTOR; NEUROTROPHIN 3; neurotrophin 4, neurotrophin 5. It plays a crucial role in pain sensation and thermoregulation in humans. Gene mutations that cause loss of receptor function are associated with CONGENITAL INSENSITIVITY TO PAIN WITH ANHIDROSIS, while gene rearrangements that activate the protein-tyrosine kinase function are associated with tumorigenesis. NTRK1 Receptor,Proto-Oncogene Protein trk,Receptor, Neurotrophic Tyrosine Kinase Type 1,gp140(c-TRK),trk Proto-Oncogene Protein,trkA Receptor,Neurotrophic Tyrosine Kinase Receptor Type 1,Proto-Oncogene Products c-trk,c-trk Protein,gp140 c-trk,p140-trkA,trk1 Transforming Tryrosine Kinase,Proto Oncogene Products c trk,Proto Oncogene Protein trk,Proto-Oncogene Protein, trk,Receptor, NTRK1,c trk Protein,c-trk, Proto-Oncogene Products,c-trk, gp140,gp140 c trk,p140 trkA,trk Proto Oncogene Protein,trk, Proto-Oncogene Protein
D020932 Nerve Growth Factor NERVE GROWTH FACTOR is the first of a series of neurotrophic factors that were found to influence the growth and differentiation of sympathetic and sensory neurons. It is comprised of alpha, beta, and gamma subunits. The beta subunit is responsible for its growth stimulating activity. NGF,Nerve Growth Factor 1,Nerve Growth Factor alpha Subunit,Nerve Growth Factor beta Subunit,Nerve Growth Factor gamma Subunit,NGF-1beta,beta-Nerve Growth Factor,Factor, beta-Nerve Growth,NGF 1beta,beta Nerve Growth Factor
D021441 Carcinoma, Pancreatic Ductal Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS. Pancreatic Ductal Carcinoma,Carcinoma, Ductal, Pancreatic,Duct-Cell Carcinoma of the Pancreas,Duct-Cell Carcinoma, Pancreas,Ductal Carcinoma of the Pancreas,Pancreatic Duct Cell Carcinoma,Carcinoma, Pancreas Duct-Cell,Carcinomas, Pancreas Duct-Cell,Carcinomas, Pancreatic Ductal,Duct Cell Carcinoma of the Pancreas,Duct Cell Carcinoma, Pancreas,Duct-Cell Carcinomas, Pancreas,Ductal Carcinoma, Pancreatic,Ductal Carcinomas, Pancreatic,Pancreas Duct-Cell Carcinoma,Pancreas Duct-Cell Carcinomas,Pancreatic Ductal Carcinomas

Related Publications

Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
October 2015, Genetics and molecular research : GMR,
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
April 2013, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
April 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
March 2019, Zhonghua wai ke za zhi [Chinese journal of surgery],
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
October 2022, Cancer reports (Hoboken, N.J.),
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
March 2015, Diagnostic pathology,
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
February 2021, Journal of gastroenterology and hepatology,
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
March 2012, Medical oncology (Northwood, London, England),
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
January 2012, Asian Pacific journal of cancer prevention : APJCP,
Ling-Xin Meng, and Zhao-Jun Ding, and Xi-Ping Chen, and Li-Sheng Fei, and Yu-Hua Chi, and Zhi-Gang Zhao, and Xiao-Fang Wang, and Xi-Shan Hao
April 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!